First Trust Advisors LP Bausch Health Companies Inc. Transaction History

First Trust Advisors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$6.28 - $9.85 $217,652 - $341,381	34,658 Added 56.86%	95,609 $774,000
Q4 2022 Feb 09, 2023	SELL	$6.09 - $7.93 $1.37 Million - $1.78 Million	-224,259 Reduced 78.63%	60,951 $382,000
Q3 2022 Nov 14, 2022	BUY	$4.58 - $9.21 $1.31 Million - $2.63 Million	285,210 New	285,210 $1.97 Million
Q4 2021 Feb 08, 2022	SELL	$23.0 - $29.01 $932,420 - $1.18 Million	-40,540 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $40,038 - $48,065	1,599 Added 4.11%	40,540 $1.13 Million
Q2 2021 Oct 12, 2021	BUY	$27.43 - $32.7 $1.07 Million - $1.27 Million	38,941 New	38,941 $1.14 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.